SUBSCRIBE
SUBSCRIBE
News   FDA

UCB, Inc. Says Keppra XR Epilepsy Drug Approved in U.S.

September 15, 2008 | 
1 min read
BRUSSELS, Sept 15 (Reuters) - Belgian pharma group UCB said on Monday that U.S. health authorities had approved epilepsy drug Keppra XR and that it would go on sale just before its mother drug loses patent protection.
FDA Approvals Europe
MORE ON THIS TOPIC
Thumb up close-up in surgical, medical gloves, gesture, recommendation for a successful operation. Pink background.
Rare diseases
FDA Greenlights First Gene Therapy for Rare Pediatric Disease
December 10, 2025
 · 
1 min read
 · 
Tristan Manalac
Silver Spring, MD, USA - June 25, 2022: The FDA White Oak Campus, headquarters of the United States Food and Drug Administration, a federal agency of the Department of Health and Human Services (HHS).
Vaccines
FDA Launches Probe Into Safety of Approved Anti-RSV Antibodies
December 10, 2025
 · 
2 min read
 · 
Tristan Manalac
Minimal Clip Art Collage. Pop Vector Design Composition with bright bold geometric shapes, halftone objects for ad, animation etc
Approvals
First Commissioner’s Priority Review Approval Goes to Decades-Old Antibiotic
December 10, 2025
 · 
2 min read
 · 
Tristan Manalac
Podcast
Weight Loss Waves, Pazdur’s Exit and FDA Instability, New Neuro Breakthroughs
December 10, 2025
 · 
1 min read
 · 
Heather McKenzie